4-(2-((2R,3R)-4-(4-(2-(4-CYANOPHENYL)-2-OXOETHYL)-1,2,4-TRIAZOL-4-IUM-1-YL)-3-(2,5-DIFLUOROPHENYL)-3-HYDROXYBUTAN-2-YL)-1,3-THIAZOL-4-YL)BENZONITRILE
UNII V5M8YVG7FP
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-((2r,3r)-4-(4-(2-(4-cyanophenyl)-2-oxoethyl)-1,2,4-triazol-4-ium-1-yl)-3-(2,5-difluorophenyl)-3-hydroxybutan-2-yl)-1,3-thiazol-4-yl)benzonitrile, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V5M8YVG7FP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H23F2N6O2S QSVGKYXGFPDLPA-PKHCJMHPSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-((2r,3r)-4-(4-(2-(4-cyanophenyl)-2-oxoethyl)-1,2,4-triazol-4-ium-1-yl)-3-(2,5-difluorophenyl)-3-hydroxybutan-2-yl)-1,3-thiazol-4-yl)benzonitrile. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.